SCHEMBL23809266

SCHEMBL23809266

CC(C)c1ccc2c(c1)CCCN2CC(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.50
PDK2 Q15119 1/20 0.50
PDK3 Q15120 1/20 0.50
PDK4 Q16654 1/20 0.50
CHRM2 P08172 4/20 0.49
CHRM4 P08173 4/20 0.49
CHRM1 P11229 3/20 0.49
CHRM3 P20309 3/20 0.49
ALDH1A1 P00352 3/20 0.44
GAA P10253 2/20 0.44
TP53 P04637 2/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
MAPT P10636 2/20 0.44
CASP1 P29466 2/20 0.44
CASP7 P55210 2/20 0.44
KMT2A Q03164 2/20 0.44
HSD17B10 Q99714 2/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12656456 0.82 CHRM2 (0.70) PDK1PDK2PDK3PDK4CHRM2
SCHEMBL14214509 0.80 HRH3 (0.49) PDK1PDK2PDK3PDK4CHRM2
SCHEMBL12656475 0.80 HDAC1 (0.57) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL12656515 0.80 HDAC1 (0.56) PDK1PDK2PDK3PDK4CHRM2
SCHEMBL12894583 0.80 ALDH1A1 (0.48) PDK1PDK2PDK3PDK4CHRM2
SCHEMBL15612833 0.76 HDAC1 (0.71) TP53HDAC1HDAC8HDAC6HDAC3
SCHEMBL4700798 0.76 ALDH1A1 (0.71) CHRM2CHRM4CHRM1CHRM3ALDH1A1
SCHEMBL28459583 0.75 PDK1 (0.64) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL13711475 0.75 PDK1 (0.64) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL17281115 0.75 ALDH1A1 (0.47) PDK1PDK2PDK3PDK4CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 PDK1 922/4885PDK2 2214/4885PDK3 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.